|
Ok, if i got this right they counted only 60 of the 100 women? If thats right and they said 57% of the 60 were Her2 pos. then 43% were Her2 neg, right. Well how the heck did they get "twice as likely to have brain mets from that?" Did i miss something?
Joe, this is why i hope they get the adjuvant Tykerb(lapatinib) trials going. If this drug could PREVENT brain mets from coming in a oral form BRING IT ON!! Are the Glaxo reps seeing this need? I hope they are!!
|